abstract |
The present invention is of formula (I) wherein A 1 , A 2 , A 3 , B, R 1 , R 2 , R 3 , and R 4 are as defined in the specification and claims. As well as the physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals. |